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he Role of Imaging in Chronic Degenerative
itral Regurgitation
atrick O’Gara, MD, FACC,* Lissa Sugeng, MD, FACC,‡ Roberto Lang, MD, FACC,‡
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regory Fischer, MD,† Blasé Carabello, MD, FACC,** David Adams, MD, FACC,†
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hronicdegenerativemitral regurgitation (MR) isacomplexproblem,which requiresan integratedassessment
f etiology, pathophysiology, and severity to enable informed clinical decision-making. A multidisciplinary
pproach is required,with input fromtheclinician, imager, andsurgeon. This reviewbeginswithadiscussionof
ssential echocardiographic and surgical mitral valve (MV) anatomy, which dictates suitability for repair when
ndicated. The echocardiographic and Doppler principles, which underlie the quantitation of MR severity, are
ummarized in the next section, followed by a critical examination of left ventricular systolic function in this
isorder. A brief discussion of the important role of imaging in the developing field of percutaneousMV repair
s included. The methodical and objective noninvasive assessment of degenerative MR herein reviewed is
ntended to help guide management decisions for patients with this challenging valve lesion. (J Am Coll
ardiol Img 2008;1:221–37) © 2008 by the American College of Cardiology Foundationr
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al Che natural history of chronic mitral
regurgitation (MR) depends intimately
on its etiology, the severity of the left
ventricular (LV) volume overload, left
nd right ventricular contractile performance,
nd the superimposition of other destabilizing
nfluences such as atrial fibrillation. Table 1
ists the most common causes of chronic MR
ith reference to the valve level(s) most com-
only affected by the specific disorders. These
auses are not mutually exclusive. There are
mportant differences in the outcomes of pa-
ients with ischemic versus nonischemic MR,
rom *Brigham And Women’s Hospital, Boston, Massachusetts; †
University of Chicago Hospitals, Chicago, Illinois; §Mayo Cli
ospital, Boston, Massachusetts; Ohio State University Medic
edical Center, Houston, Texas.anuscript received January 7, 2008; accepted January 28, 2008.elated both to the effects of recurrent myocar-
ial ischemia and to the significant contribu-
ion of LV remodeling to survival and function.
he approach to nonischemic MR, which will
e the focus of this review, may lend itself to a
ore uniform set of principles focused more
pecifically on the valve lesion and LV function.
The management of chronic nonischemic
R poses a unique set of challenges, predi-
ated in part on the more diverse causes of this
alve disorder, the difficulty in assessing LV
ontractile performance in the setting of re-
uced afterload, the subtle and oftentimes late
nt Sinai Medical Center, New York, New York;
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222ppearance of symptoms, the misapplication of
asodilator therapy, uncertainty regarding the indi-
ations for surgery in the asymptomatic patient, and
he still-evolving adoption of operative repair tech-
iques. The potential role of percutaneous mitral
alve (MV) repair is the subject of active investiga-
ion. Recent improvements in surgical outcomes
ave frame-shifted the timing of operation earlier in
he natural history of appropriately selected patients
ith chronic nonischemic MR and have forced
linicians to balance the upfront risks of surgery
death, stroke, bleeding, failure of repair) versus the
elayed consequences of progressive LV volume
overload (heart failure, atrial fibrillation,
death) which, for some patients, may not
develop for decades, if at all. To date,
large-scale randomized controlled clinical
trials comparing different treatment strat-
egies have been lacking. Comparisons
across available registry and single-center
studies have been hampered by several
factors, including varying definitions of
MR severity, heterogeneous patient pop-
ulations, selection bias, lack of standard-
ized medical and surgical therapies, and
dissimilar surrogate and clinical end
points. Management strategies have there-
fore evolved empirically, and guidelines have
relied more on expert consensus opinion
than on objective measures of efficacy and
safety. Because the data available from sim-
ple bedside assessment are inherently impre-
cise and because the consequences of clinical
decision-making are potentially so pro-
found, additional information is required to
make appropriate treatment recommenda-
tions. Noninvasive imaging and, in particu-
lar, echocardiography, helps fill this void and
plays a critical role in the initial and longi-
tudinal assessment of patients with chronic
MR. In this review, we will examine the
pplication of standardized, noninvasive imaging to
edical and surgical decision-making in patients with
hronic, nonischemic MR. Critical components of the
oninvasive evaluation include information regarding
V anatomy, MR severity, LV size and systolic
unction, and associated findings such as estimated
ulmonary artery (PA) pressures. In most instances,
uch information can be obtained with standardized
chocardiographic protocols, although cardiac mag-
etic resonance (CMR) and computed tomography
ay provide supplementary information in se-
t
n
tected patients. mitral Valve Anatomy
ormal MV anatomy. The MV is a complex
-dimensional (3D) structure comprising 5 distinct
ut highly integrated levels:
EAFLETS. The MV has 2 leaflets, namely anterior
AML) and posterior (PML) leaflets (Fig. 1). The
ML has a quadrangular shape and is attached to
pproximately three-fifths of the annular circumfer-
nce. It typically has 2 well-defined indentations
hat divide it into 3 individual scallops identified as
1 (anterior or medial scallop), P2 (middle scallop),
nd P3 (posterior or lateral scallop), according to
he Carpentier classification. The 3 opposing seg-
ents of the AML are designated as A1 (anterior
egment), A2 (middle segment), and A3 (posterior
egment). The segmental differentiation of the leaf-
ets is an important tool to describe specific ana-
omic conditions. The PML indentations are be-
ieved to aid in leaflet opening during diastole. The
eight of the normal PML is less than one-half of
he AML. However, both leaflets have similar
urface areas. The AML has a semicircular shape
nd attaches to approximately two-fifths of the
nnular circumference. The fibrous continuity be-
ween the AML and the aortic annulus in the area
f the left and noncoronary cusps is designated the
ortic-mitral curtain. The free edge of the AML is
sually continuous, without indentations. The mo-
ion of the AML defines an important boundary
etween the inflow (during diastole) and outflow
during systole) tracts of the LV. A rough or
oaptation zone exists on the atrial surface of the
eripheral leaflet margins (Fig. 2). The normal MV
ay have a coaptation length of several millimeters
o ensure valve competency against normal end-
ystolic pressure.
OMMISSURES. The commissures define a distinct
rea where the AML and PML come together. The
mount of commissural tissue varies greatly; com-
issures may exist as distinct leaflet segments,
imilar to adjacent segments of the PML. More
ommonly, the commissures constitute several mil-
imeters of leaflet tissue, which provide continuity
etween the AML and PML at their annular
nsertion. Commissural chordae have a distinct
onfiguration, providing support to the commissure
s well as to adjacent leaflet segments. In Carpen-
ier’s segmental anatomy, the anterior-lateral com-
issure is referred to as AC and the posterior-B B R E V I A T I O N S
N D A C R O N YM S
ML anterior mitral leafle
MR cardiac magnetic
esonance
S coronary sinue
DV end-diastolic volume
F ejection fraction
RO effective regurgitant
rifice area
SD end-systolic dimensio
SV end-systolic volume
CV great cardiac vein
A left atrium
V left ventricular
Rmitral regurgitation
Vmitral valve
ISA proximal isovelocity
urface area
ML posterior mitral leafle
F regurgitant fraction
Vol regurgitant volume
V stroke volume
EE transesophagealedial commissure as PC.
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223HORDAE. The chordae tendineae make up the
eaflet suspension system that ultimately determines
he position of and tension on the leaflets at
nd-systole. Chordae originate from the fibrous
eads of the papillary muscles and may be classified
ccording to their site of insertion on the leaflets.
arginal or “primary” chordae insert on the free
argin of the leaflets, prevent marginal prolapse,
nd align the rough zones to ensure coaptation.
ntermediate or “secondary chordae” insert on the
entricular surface of the body of the leaflets and
rimarily prevent billowing and reduce tension on
Figure 1. Example of Mitral Valve With Type IIIb Dysfunction
The operative view is shown (left), and the corresponding “surgical
volume rendering (right). Abbreviations: A1, A2, A3  anterior mitr
Table 1. Chronic Mitral Regurgitation
Etiology
Chronic coronary artery disease
Ischemic MR
Myxomatous degeneration
Mitral valve prolapse
Barlow’s valve
Nonischemic dilated cardiomyopathy
Rheumatic heart disease
Healed infective endocarditis
Hypertrophic obstructive cardiomyopathy
Mitral annular calciﬁcation
Congenital
Connective tissue diseases
Rheumatoid arthritis
Systemic lupus erythematosus
Antiphospholipid antibody syndrome
Radiation
Drug
Ergotamines
Methysergide
Pergolide
(fenﬂuramine, dexfenﬂuramine)
AML  anterior mitral leaﬂet; LV  left ventricular; MR  mitral regurgitation.valve scallops, PM  postero-medial. From Mount Sinai Medical Centereaflet tissue (Fig. 3). They may also play a role in
ynamic ventricular shape and function, because of
heir contribution to ventricular-valve continuity.
asal or “tertiary chordae” connect the base of the
ML and mitral annulus to the papillary muscle.
HE ANNULUS. The mitral annulus constitutes the
natomical junction between the LV and the left
trium (LA) and serves as the insertion site for the
leaflets. It is divided segmentally into anterior
nd posterior components. The anterior portion
f the mitral annulus attaches to the fibrous
” obtained with real-time 3D transesophageal echocardiography
lve scallops, AL  anterolateral; P1, P2, P3  posterior mitral
Affected Valve Level(s)
LV, papillary muscles, annulus
Leaﬂets, chordae, annulus
LV, papillary muscles, annulus
Leaﬂets, chordae
Leaﬂets, chordae
AML, papillary muscles, LV
Annulus, leaﬂets
Anterior leaﬂet
Leaﬂets, annulus
Leaﬂets, chordae
Leaﬂets, chordaeview
al vaand University of Chicago.
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224rigones. The right fibrous trigone comprises
ortions of the mitral, tricuspid, and aortic annuli
nd the membranous septum. The left fibrous
rigone is an area made up of the left fibrous
orders of the aortic-mitral curtain. The poste-
ior mitral annulus is less well developed, and the
brous skeleton of the heart is discontinuous in
Figure 2. Systematic Interrogation of the MV With 2D TEE
(A) 4-chamber view obtained at 0° depicting A2 on the left and P2
ing the transducer tip to 55° showing P3 on the left, A2 in the mid
the transducer to 90° to visualize P3 on the left and the 3 scallops
obtained by further rotating the transducer to 120° to view P2 on t
images (as visualized from the left atrial perspective) obtained with
the approximate cut planes from which the respective 2D TEE imag
medial aspect of MV; MV  mitral valve; TEE  transesophageal ec
Medical Center and University of Chicago.his region, explaining why the posterior portion pf the annulus is prone to enlarge with LV or LA
ilation. The mitral annulus has a 3D saddle
hape. During systole, the circumference de-
reases as the commissural areas move apically,
he aortic root bulges and the annulus contracts.
APILLARY MUSCLES AND THE LV. There are 2
the right. (B) Bicommissural view obtained by electronically rotat-
and P1 on the right. (C) 2-chamber view obtained by rotating
e anterior mitral valve leaﬂet on the right. (D) Long-axis view
eft and A2 on the right. The left column correspond to MV
use of real-time 3D-TEE volume rendering. Red lines represent
ere obtained. Ao  aorta; Lat  lateral aspect of MV; Med 
rdiography; other abbreviations as in Figure 1. From Mount Sinaion
dle,
of th
he l
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hocaapillary muscles rising from the area between the
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225pical and middle third of the left ventricular free
all. The anterolateral papillary muscle is often
omposed of one body or head, whereas the pos-
eromedial papillary muscle may have 2 or more
eads. Each papillary muscle provides chordae to
oth leaflets. The axial relationship of the chordae
revents abrasion and dyssynchrony. The anterolat-
ral papillary muscle blood supply may originate
rom one or more left coronary branches. The
osteromedial papillary muscle has a singular blood
upply (right or left circumflex depending on dom-
nance) and is therefore particularly prone to injury
rom myocardial infarction. The attachment of the
apillary muscles to the lateral wall of the LV
eans the ventricle itself is also an important part of
he MV complex. Any change in ventricular geom-
try that affects papillary muscle position can
hange the axial relationship of the chordae and
eaflets, resulting in poor coaptation.
athophysiologic MV anatomy. Carpentier et al. (1)
lso have proposed a pathophysiologic triad by
hich MR can be described. The triad consists of
Figure 3. Intra-Operative 2D and 3D TEE Depiction of MV Prola
Schematic (upper row) and 2D as well as 3D echocardiographic exa
valve prolapse (P1, middle panels) and a ﬂail mitral valve (P2, right
views (middle row) and real-time 3D TEE volume rendering from th
with real-time 3D TEE provide unique visualization and better unde
commissures and leaﬂets. Abbreviations as in Figures 1 and 2.he disease (the underlying etiology, such as Bar- oow’s disease or fibroelastic deficiency), the lesions
e.g., chordal elongation or rupture, leaflet disten-
ion, annular, leaflet and/or papillary muscle calci-
cation, and annular dilation), and the dysfunction
defined according to the systolic position of the
eaflet margins in relation to the annular plane).
ype I dysfunction implies normal leaflet motion
ith isolated annular dilation, leading to poor
eaflet coaptation. Type II dysfunction is defined by
xcess motion of the margin of a leaflet segment
bove the annular plane and is the most common
ype of dysfunction in degenerative MV disease. Re-
tricted motion of the leaflet margin defines Type III
ysfunction, which can be further subdivided based on
estriction of motion in both systole and diastole
Type IIIa—usually due to fibrosis of the subvalvular
pparatus) or only in systole (Type IIIb, which usually
esults from ventricular remodeling with papillary
isplacement and leaflet tethering). Although most
atients with degenerative disease present with
hordal elongation or rupture with Type II dysfunc-
ion and associated annular dilation, any combination
and Leaﬂet Flail
les of a patient with a normal mitral valve (left panels), mitral
els) as visualized with 2D TEE (long-axis mid esophageal TEE
ft atrial perspective (bottom row). The surgical views obtained
nding of the anatomic relationships of the mitral valve annulus,pse
mp
pan
e le
rstaf dysfunction can occur based on the lesions.
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226The 2 main causes of degenerative MV disease
re Barlow’s disease and fibroelastic deficiency (2,3).
arlow’s disease results in myxoid degeneration of
he MV, creating excess tissue in multiple valve
egments, chordal thickening and elongation, an-
ular dilation, and a tendency to calcification.
hordal rupture is relatively uncommon. The Type
I dysfunction observed in Barlow’s patients occurs
n midsystole, resulting in a nonejection click and a
id- to late-systolic murmur due to chordal elon-
ation and excess tissue. Barlow’s disease is usually
iagnosed in young adulthood, and patients often
emain asymptomatic with well-preserved LV size
nd function for many years. In contrast, fibroelastic
eficiency results from loss of mechanical integrity
ue to abnormalities of connective tissue structure
nd/or function, leading to chordal thinning, elon-
ation, and/or rupture, with classic findings of
rolapse and MR of varying severity. The prolaps-
ng segment may be distended, but the remaining
egments of the valve may be entirely normal.
ibroelastic deficiency is the most common form of
rganic mitral valve disease for which surgery is
equired. The noninvasive assessment of these 3
athophysiologic elements informs clinical decision-
aking and helps direct surgical referral and planning.
ncreasing degrees of complexity should prompt pref-
rential referral to a specialized center of excellence.
urgical and echocardiographic MV anatomy. The
V can be displayed in 3 different ways as shown in
igures 4A to 4C. The anatomically correct orien-
ation displays the valve from the base of the heart
s if the imager were positioned in the left atrium
ooking down toward the LV. In this view, the
atient’s left and right side correspond to the
mager’s left and right side, whereas the AML and
ML appear in their appropriate positions. The
Figure 4. Mitral Valve Displays
(A) Anatomical view. (B) Transesophageal view (MV view as visualiz
these examples were obtained with the use of real-time 3D transes
The mitral valve is visualized from the left atrial perspective. From M
as in Figure 1.ateral and medial aspects of the valve are to the left
nd right, respectively. The transesophageal view
orresponds to the orientation of the MV found in
he transgastric basal short axis view (Fig. 4B). This
natomically “incorrect display” used in all ultra-
ound platforms results from rotating the anatom-
cal view 180°. In this view, the operator’s left and
ight sides are reversed relative to the patient. The
urgeon’s view (Fig. 4C), which can be easily
btained with real-time transesophageal echocardiog-
aphy (TEE), displays the valve in a manner similar to
he one encountered when examining it through an
pened LA, standing to the right of the patient.
A systematic 2D TEE examination of the MV
onsists of 4 standard midesophageal views (4-
hamber, bicommissural, 2-chamber, and long-axis
iews) and the transgastric basal short-axis view
Fig. 2). It should be noted that the classification of
he MV scallops in any given plane may vary
ccording to the individual anatomy. It is crucial to
nsure that the imaging plane does not fore-shorten
he LV because this may lead to misidentification of
he individual scallops. Accordingly, orientation to
nternal landmarks such as the commissures is
aramount to enhance diagnostic accuracy. This
ystematic approach is also useful in identifying the
ncompetent segment. A regurgitant jet arising
rom the left coaptation point indicates involvement
f P3/A3, whereas a jet arising from the right
uggests involvement of A1/P1. With the use of 3D
EE, the MV annulus and leaflets are best dis-
layed when obtained in zoom mode to avoid stitch
rtifacts that may occur in a wide-angled acquisi-
ion. To simulate a surgeon’s view of the valve, the
D TEE image is positioned with the aortic valve at
he 11-o’clock position (Fig. 1). The LV view is
nother orientation from which to assess the valve,
n the transgastric basal short axis view. (C) Surgeon’s view. All
ageal echocardiography volume rendering using zoomed views.
nt Sinai Medical Center and University of Chicago. Abbreviationsed i
oph
ou
p
s
r
w
w
s
l
d
fl
3
t
a
n
a
f
a
3
c
t
p
a
s
o
m
d
b
T
f
Q
Q
d
p
m
c
e
e
i
s
A
A
o
t
a
i
e
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 2 , 2 0 0 8
M A R C H 2 0 0 8 : 2 2 1 – 3 7
O’Gara et al.
Role of Imaging in Chronic Degenerative MR
227articularly in patients with pathology involving the
ubmitral apparatus. If the subvalvular mitral appa-
atus or LV constitutes the area of interest, a
ide-angled acquisition consisting of 4 smaller
edges of volume obtained over 4 cardiac cycles
hould be obtained to demonstrate papillary muscle
ocation or quantitate LV function. Figures 5 and 6
emonstrate examples of patients with mitral valve
ail and prolapse as visualized with 2D TEE and
D TEE.
The 3D TEE parameters of interest include: 1)
he major 3D axes of the annulus, anteroposterior
nd anterolateral-posteromedial diameters, and an-
ular height; 2) 3D curvilinear leaflet lengths of the
nterior middle scallop, across its central portion
rom the annulus to the central coaptation border
nd of the corresponding posterior middle scallop;
) anterior and posterior leaflet surface areas, ex-
luding the leaflet contact areas; 4) the angle be-
ween the aortic valve annulus (assumed to be
lanar) and a least-squares fit plane of the mitral
nnulus; and 5) the distances between the commis-
ures and papillary muscles (Fig. 7). Measurement
f these parameters may aid in understanding the
Figure 5. Example of a Patient With a P2 Flail Mitral Valve
Examples of patients with P1 prolapse (top left); P2 ﬂail mitral valv
P3 ﬂail mitral valve (black arrow, bottom left); and Barlow’s syndro
P3) (bottom right). All images were obtained with real-time 3D-TEE
perspective.echanism of MR, improve surgical planning, and
elineate annular and annuloplasty ring dynamics
efore and after operation. Higher-resolution 3D
EE images enable improved quantitation of LV
unction.
uantitation of MR
uantitation of MR severity is essential for clinical
ecision-making. Referral for surgery is not appro-
riate for the asymptomatic patient without confir-
ation that the MR is severe by standardized
riteria. The use of descriptive terms such as “mod-
rately severe” can be highly subjective and influ-
nced by any one of several treatment biases. The
mportance of MR quantitation has been empha-
ized by the guideline writing committees of the
merican College of Cardiology/American Heart
ssociation and the European Society of Cardiol-
gy (4). The severity of MR, in turn, should dictate
he associated degree of LV and LA enlargement,
s well as PA pressure elevation, in patients with
solated valve disease. The use of 2D Doppler
chocardiographic quantitation proves sufficient for
allop (black arrow) with a ruptured chord (red arrow, top right);
with ﬂoppy mitral valve with multiple leaﬂet prolapse (P1, P2 and
ume rendering. The mitral valves are visualized from the left atriale sc
me
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228ost patients, though 3D TEE and CMR may
rovide more accurate information in selected cases.
rinciples. A comprehensive approach to the assess-
ent of MR severity is required. Specific findings
elated to MV anatomy, supportive findings, which
nclude chamber sizes, intra-cardiac flows, and PA
ressures, as well as quantitative findings regarding
egurgitant volume (RVol) and effective regurgitant
rifice area (ERO), constitute the basic features of
n integrated assessment. Reporting of MR severity
hould be consistent with the ASE criteria for
escriptive and semi-quantitative grading shown in
able 2.
ualitative echo-Doppler assessment. The entire
Figure 6. Correlative 3-D and 2-D TEE MV Anatomy
Example of a patient with a P2 ﬂail mitral valve. (A) Four-chamber v
Two-chamber view obtained by rotating the transducer to 90° to vi
leaﬂet on the right; (C) Long-axis view obtained by further rotating
A2 on the right. The direction of the color jet in the long-axis view
umn images correspond to the mitral valve image (as visualized fro
rendering. The red arrows represent the approximate cut planes fro
scallops of the anterior mitral valve and P1, P2, P3  scallops of thV apparatus should be examined carefully and the color scale optimized. Mild MR is characterized
ualitatively as a small jet confined to early or late
ystole with small/absent flow convergence and a
arrow vena contracta. In the absence of intrinsic
V systolic or diastolic dysfunction, the LV and the
A dimensions also are normal. Qualitative assess-
ent of larger or more eccentric jets is more
ifficult. Flail leaflet or ruptured papillary muscle
ost often is associated with severe MR, although
he regurgitant load may be only moderate by
uantitative criteria in as many as 15% of patients.
ystolic flow reversal in the pulmonary veins by
ulsed-wave Doppler is relatively easy to demon-
trate and is specific for severe MR. Other signs
obtained at 0° depicting A2 on the left and P2 on the right; (B)
ize P3 on the left and the 3 scallops of the anterior mitral valve
transducer to 120° to view the ﬂail P2 segment on the left and
ttom left) is away from the side of the ﬂail lesion. The left col-
he left atrial perspective) obtained using real-time 3D-TEE volume
hich the respective 2D TEE images were obtained. A1, A2, A3 
sterior mitral valve.iew
sual
the
(bo
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m wonsidered specific for severe MR are the presence
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229f a large flow convergence, a jet with a wide vena
ontracta, and a large, wall-impinging or swirling
et pattern. Interpretation of these signs is subject to
ide interobserver variability. High jet density by
ontinuous-wave Doppler, a dominant mitral E,
nd dilated LA and LV chambers, support the
iagnosis of severe MR. There are several addi-
ional limitations to the qualitative assessment of
R. First, there are no specific criteria for the
esignation of moderate MR, other than the ab-
ence of findings consistent with either mild or
evere MR (4). Second, interpretation of color flow
atterns of MR can be highly subjective, thus
lurring the distinction between moderate and se-
ere. It is widely appreciated that eccentric jets tend
o underestimate and central jets to overestimate
Vol (5). Third, although specific signs have high
ositive predictive value, they lack sensitivity for the
etection of severe MR. These limitations have led
o the development of quantitative methods for
ssessment of MR (4).
uantitative Doppler echocardiographic assessment.
uantitation is based on hydrodynamic principles
hich rely on the noncompressibility of blood and
he continuity or conservation of mass. Flow can be
Figure 7. Examples of 3D Renderings of the Mitral Valve Obtain
Quantitative Analysis of the Mitral Apparatus
Examples of 3D renderings of the mitral valve obtained from 3D-TE
mitral apparatus. (Top, Left) Antero-posterior diameter is shown in
let surface area (hatched) with posterior middle scallop leaﬂet prola
 anterior, P  posterior, AL  anterolateral, PM  posteromedial,alculated as: flow  (vessel area) · (mean velocity of clood). These concepts are used to measure the 3
arameters indicative of MR severity: 1) RVol (the
olume in ml/beat regurgitated each systole), a mea-
ure of absolute volume overload; 2) regurgitant
raction (RF, the percentage of the total LV stroke
olume represented by the RVol), a measure of
elative volume overload; and 3) ERO (the mean
rea of the systolic regurgitant orifice), a measure of
esion severity.
These parameters of MR severity are measured
ith the use of 3 validated methods: 1) quantitative
oppler (4) is based on measurement by pulsed-
ave Doppler of mitral and aortic stroke volumes
sing the product of mitral and aortic annular areas
imes their integral of forward blood velocity (tissue
elocity integral [TVI]). Regurgitant volume is
alculated as the difference between mitral and
ortic stroke volume, RF as the ratio of RVol to
itral (total) stroke volume, and ERO as the ratio
Vol to the regurgitant jet TVI; 2) quantitative 2D
chocardiography (4) is based on the same princi-
les, but mitral stroke volume is replaced by that of
V stroke volume by tracing end-diastolic and
nd-systolic LV volumes; and 3) proximal isoveloc-
ty surface area (PISA), which focuses on the flow
From 3D-TEE Data Set With Software Designed for
taset using software designed for quantitative analysis of the
n. (Top, Right) Annular height. (Bottom Left) Anterior mitral leaf-
. (Bottom, Right) Angle between the mitral and aortic annuli. A
 aorta, TEE  transesophageal echocardiography.ed
E da
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230Fig. 8), as observed with color-flow imaging (6).
he color scale baseline is shifted downward to
nsure measurability of the flow convergence radius
nd velocity. Flow through the convergence zone (and
ence through the regurgitant orifice) is calculated as
he product (area of flow-convergence hemisphere) ·
aliasing velocity). This velocity term is indicated by
he machine (junction blue-yellow). Effective regurgi-
ant orifice area is calculated as the ratio of flow to
eak regurgitant velocity and RVol as the product of
ERO) · (regurgitant TVI) (7). Thus, it is possible
uring a single examination to measure RVol and
RO by the use of multiple methods.
Figure 8. Principles of the PISA Method of MR Quantitation
The ﬂow convergence is indicated by the large open hemi-
sphere observed in perspective and the jet of MR by the large
arrow at the bottom. V1 is the velocity on the ﬂow conver-
gence hemisphere (white arrows) whereas the jet velocity is
V2. The right side indicates the calculation of regurgitant ﬂow
(Flow 2) and effective regurgitant oriﬁce area (ERO). R is the
radius of the hemisphere of ﬂow convergence. MR  mitral
Table 2. Grading MR by Doppler Echocardiography
Additional Wording Mild
Angiographic grading 1
Speciﬁc signs ● Small central jet area 4 cm2
or 20% of LA
● Vena contracta width 0.3
cm
● No or minimal ﬂow
convergence
Supportive signs ● Systolic dominant ﬂow in
pulmonary veins
● A-wave dominant mitral
inﬂow
● Low density CW-Doppler MR
signal
● Normal LV size
● Normal LA size
Quantitative parameters
RVol, ml/beat 30
RF, % 30
ERO, cm2 0.20
Modiﬁed from Zoghbi et al. (4).
ERO  effective regurgitant oriﬁce area; LA  left atrium; LV  left ventricle;g
regurgitation; PISA  proximal isovelocity surface area.ccuracy and reproducibility. Quantitation requires
ttention to detail, repetition, and quality control.
he PISA method requires close zooming and
ownshift of the color baseline tailored to obtain an
nconstrained flow convergence of almost circular
hape (Fig. 9). The flow convergence radius should
e measured at peak regurgitant velocity, which
sually occurs near the T-wave on the electrocar-
iogram. Regurgitant flow, and therefore ERO,
ay vary throughout systole as a function of the
ause of the MR. Continuous-wave Doppler should
e recorded with a single-crystal transducer, and
ttention paid to avoid incorporation of partial
ystolic signals (early and late). Simplified estimates
f RVol may be derived from the ratio of flow/3.25.
ultiple measurements of these parameters should
e made and the values for RVol and ERO averaged.
Emerging technologies for the assessment of MR
everity may prove useful. Real-time 3D TEE holds
romise for volume measurement, jet characteriza-
ion, and definition of proximal flow convergence.
ardiac magnetic resonance is of limited value for
ssessment of MV structure and motion, but it can
e use to provide highly accurate quantitation of LV
nd regurgitant volumes. The ERO measurements
annot be reliably obtained with this technique.
nterpretation and integration. The qualitative and
uantitative characterization of MR must be inte-
Moderate
Severe
ild to
oderate
Moderate to
Severe
3 4
R more than mild, but no
criteria for severe MR
● Vena contracta width 0.7cm
with large central MR jet (area
40% of LA) or with a wall-
impinging jet of any size.
● Large ﬂow convergence
● Systolic ﬂow reversal in
pulmonary veins
● Prominent ﬂail leaﬂet or
ruptured papillary muscle
R more than mild, but no
criteria for severe MR
● Dense, triangular continuous-
wave Doppler signal
● E-wave dominant mitral
inﬂow (E 1.2 m/s)
● Enlarged LV and LA size,
(particularly with normal LV
function)
30–44 45–59 60
30–39 40–49 50
20–0.29 0.30–0.39 0.40
 mitral regurgitation; RF  regurgitant fraction; RVol  regurgitant volume.M
M
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231al treatment and long-term follow-up. For pa-
ients with isolated mild or moderate nonischemic
R with preserved LV size and function, expectant
anagement with periodic surveillance is appropri-
te. It is for patients with isolated, severe MR that
iming of surgery becomes critical. Many such
atients are asymptomatic and thus reliance on
bjective and standardized noninvasive data is nec-
ssary for clinical decision-making. Designation of
R as severe must be verifiable across the spectrum
f parameters reviewed above and summarized in
able 2.
he LV in Chronic MR
igure 10 depicts the stages that an untreated
atient with severe MR might experience (8). In
cute, severe MR (Fig. 10B), there is sudden
istension of the LA, producing LA hypertension
nd pulmonary congestion. Increased LV preload is
anifested by slightly increased end diastolic vol-
me (EDV) whereas the regurgitant pathway for
jection into the LA decreases LV afterload and
nd systolic volume (ESV). These changes act in
oncert to increase total stroke volume (SV) but not
nough to normalize forward SV. Thus, the patient
as decreased forward output and pulmonary con-
estion and is in heart failure despite normal LV
ontractile function. If the patient survives the acute
nsult and is left untreated, or if the MR develops
0.22 
Aliasing 
velocity
ERO = flow/v
Flow = 336 mL/sec 
1.6
LV 
LA 
R = 1.56 
x 
+ 
Figure 9. Calculation of PISA Derived ERO
The left image is a zoomed view of the ﬂow convergence zone wit
an aliasing velocity of 22 cm/s. The radius (R) of the ﬂow convergen
at 336 ml/s. The right image shows continuous-wave Doppler mea
is calculated at 67 mm2 or 0.67 cm2, as the ratio of ﬂow to velocityore gradually over time, he or she may enter a ehronic compensated phase (Fig. 10C). In this
hase, eccentric hypertrophy has developed, in-
reasing EDV. The radius term in the Laplace
quation is increased, but systolic wall stress does
ot increase. The increase in EDV more than
ffsets the increase in ESV, so that total SV is
ncreased, in turn increasing forward SV. An en-
arged, compliant LA can accommodate the RVol
t lower pressure, relieving pulmonary congestion.
n this phase, the patient may be completely asymp-
omatic. How long the patient remains in this phase
s quite variable, depending on whether the MR
orsens and probably on genetic variations in tol-
rance of the volume overload. Eventually, severe
R leads to muscle dysfunction and decompensa-
ion (Fig. 10D). In this phase, a weakened LV can
o longer shorten adequately and ESV increases,
ecreasing total and forward SV while increasing
A and LV filling pressures. Symptoms of heart
ailure may develop, but some patients remain
symptomatic or fail to recognize deterioration in
unctional status. Importantly, ejection fraction
EF) may remain in the “normal” range, belying the
resence of LV dysfunction (9).
jection fraction. Ejection fraction has, during the
ast 4 decades, become the most widely used de-
criptor of LV function. All imaging techniques can
e used to determine LVEF. However, the issue at
and for the clinician is to determine whether or
ot the patient with MR is entering the phase of
city = 67 mm2
 
 
 
MR velocity = 500 
lor-ﬂow imaging and down-shifting of the baseline resulting in
is measured using the 2 crosses shown and the ﬂow is calculated
ment of the peak regurgitant velocity (MR velocity). The ERO area
 left ventricle; other abbreviations as in Figure 8.elo
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232ion of MR must be undertaken to prevent perma-
ent myocardial damage. The major function of any
uscle including the myocardium is to develop
orce. Obviously, EF has no force term in its
xpression. What the clinician would like to know
s whether contractility, the innate ability of the
yocardium to generate force, has begun to decline.
he ideal measure of contractility would be a
easure independent of afterload and preload, sen-
Figure 10. The Pathophysiologic Stages of MR
(A and B) Normal physiology (N) is contrasted with that of acute
MR increases sarcomere length (SL), augmenting preload. Increas
The new pathologic pathway for ejection into the left atrium (LA
allowing the left ventricle to eject more completely. Enhanced e
result, the total stroke volume increases to 140 ml, but because
ward stroke volume (FSV) decreases. Ejection fraction (EF) increa
(C) Chronic compensated mitral regurgitation. In this phase of M
EDV, which allows for a large increase in total stroke volume (19
pliant LA can accommodate the regurgitant volume at a lower p
and EF remains increased. (D) Chronic decompensated mitral reg
age caused by prolonged severe volume overload. Impaired CF r
increases. There is a further increase in diastolic volume, which i
in total and forward stroke volumes. Concomitantly, increased ED
alignment and regurgitant fraction increases. Ejection fraction is
normal range.itive to changes in inotropic state, insensitive to eV size, and easy to apply (10). Unfortunately, no
uch measure exists but EF, which is easy to apply,
as become the cornerstone of LV function
ssessment.
Unfortunately, EF is especially suspect in pa-
ients with MR because it is load sensitive and both
fterload and preload are altered in patients with
R (11). Increased pre-load and reduced afterload
ct in concert to increase EF beyond what would be
tral regurgitation (MR). In acute MR, the volume overload of
SL is reﬂected by an increase in end-diastolic volume (EDV).
duces afterload as quantiﬁed by end-systolic stress (ESS),
on is reﬂected by a fall in end-systolic volume (ESV). As a
is regurgitated into the LA (regurgitant fraction [RF] 0.50), for-
although contractile function (CF) is normal but not increased.
ccentric cardiac hypertrophy produces a further increase in
l) so that FSV returns to nearly normal. The enlarged and com-
ure, so that left atrial pressure declines. CF remains normal,
itation. In this phase, CF has been reduced from muscle dam-
ces the effectiveness of left ventricular ejection and ESV
t compensatory for the increase in ESV, resulting in a decrease
orsens the MR by annular dilation and papillary muscle mal-
uced from the compensated state but often remains within themi
ed
) re
jecti
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233ubstantial LV dysfunction may still have a normal
F (9,12) To overcome this deficiency the clinical
se of EF in MR patients, a greater limit for normal
as been set. Although in most subjects the lower
imit of normal for EF is 0.55, MR patients with
F 0.60 have been noted to have an impaired
rognosis (9,13). The EF is further compromised
ecause it is often estimated rather than measured
recisely, making it unclear whether the distinction
etween an EF of 0.60 and 0.55 is accurate. Because
f the imprecision of EF in assessing LV function,
specially in MR, other measures have been ex-
lored.
nd-systolic dimension (ESD) and volume. A number
f studies have examined whether ESV or ESD is
redictive of outcome in chronic MR (14–16). The
olume to which the LV contracts at the end of
ystole is determined by contractility, afterload, and
ccentric remodeling, but not by pre-load. Thus,
SV and ESD are independent of one of the factors
onfounding the use of EF in assessing LV function
n MR. Additionally, afterload tends to increase in
he late stages of MR whereas, at the same time,
ontractility tends to decrease. An increased LV-
SD (40 mm) and an LVEF 0.60 are indica-
ors of LV systolic dysfunction, portend poor long-
erm prognosis, and generally are accepted as
ndications for surgery even in the absence of
ymptoms (17). Thus, the determination of ESV or
SD is an important component of the noninvasive
ssessment of patients with MR. Left ventricular
imensions can be accurately obtained with 2D
echniques. Volume determinations are more pre-
ise with 3D TEE and CMR.
ontractile reserve. The response to exercise stress
ssessed with echocardiography has also been used
o identify subclinical LV systolic dysfunction in
atients with asymptomatic MR. Impaired con-
ractile reserve with exercise (defined as an in-
rease in EF 0.04) has been shown to predict
orsening LV function in medically treated pa-
ients. Reduced reserve also helps to predict
mmediate post-operative LV systolic dysfunc-
ion and early cardiac events in patients under-
oing surgery (18).
yocardial function. Doppler imaging of LV myo-
ardial segments has been used as a surrogate
arker of LV function (19). Systolic tissue Doppler
elocities have been shown to correlate with LV
unction, to identify subclinical LV dysfunction,
nd to predict post-operative LV function in pa-
ients with asymptomatic MR (20,21). pMyocardial strain is defined as a change in length
ompared with a reference initial length. In contrast
o velocity of contraction, strain imaging is not
nfluenced by global cardiac motion but may be
nfluenced by large variations in loading conditions
22). Strain rate is the change of strain over time
23). Both strain and strain rate have been demon-
trated to correlate well with LV function, wherein
train appears to correlate with the stroke volume
nd strain rate with LV contractility assessed by
nvasively derived dP/dt (24). Strain and strain rate
elp identify subclinical LV dysfunction in patients
ith asymptomatic severe MR and correlate with
ontractile reserve with exercise; strain and strain
ate are significantly greater in patients with ade-
uate contractile reserve (25). Moreover, strain and
train rates have been shown to decrease even before
hanges in LV chamber dimensions occur, i.e., before
V systolic dimension exceeds 4.5 cm (26). Limita-
ions of strain imaging include its dependence on
re-load, afterload, and imaging angle. To correct for
he influence of preload on strain/strain rate and
btain a more pure measure of contractility, Marciniak
t al. (26) devised geometry-compensated deforma-
ion indices, which are calculated by dividing strain
nd strain rate by EDV. The geometry compensated
eformation indices are decreased in patients with LV
ystolic dimension4.5 cm (22). However, the incre-
ental value of accurately identifying preclinical LV
ysfunction remains to be determined.
ole of Imaging in Ongoing Investigations
f PercutaneousMV Repair
ecently, there has been considerable interest in
ercutaneous MV repair. One approach, which
dopts the principles of the Alfieri surgical tech-
ique, involves the deployment of a clip or stitch to
ring the leaflet edges together (Fig. 11). In the
rocess, a double orifice valve is created. A second
pproach aims to reduce mitral annular circumfer-
nce via placement of a device in the coronary sinus
Fig. 11). These coronary sinus devices reshape the
osterior mitral annulus.
Pre-, intra-, and post-procedural imaging is crit-
cal to the successful use of these devices. There are
basic imaging objectives: 1) evaluate the mecha-
ism and severity of MR; 2) determine anatomic
uitability for device repair; 3) guide deployment of
he device; and 4) assess stability and outcome of
epair. Table 3 lists key imaging factors for each of
he percutaneous techniques. For edge-to-edge re-
air, TEE is the most widely used approach to
i
g
c
c
t
l
h
e
w
u
d
C
s
a
b
a
M
v
v
t
t
a
c
g
v
e
g
t
s
C
m
w
m
m
h
p
t
E
t
o
a
a
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 2 , 2 0 0 8
M A R C H 2 0 0 8 : 2 2 1 – 3 7
O’Gara et al.
Role of Imaging in Chronic Degenerative MR
234dentify the location of abnormal anatomy, and
uide the procedure. Mid-esophageal long-axis and
ommissural TEE views are particularly helpful to
enter the clips over the MV orifice, and the
ransgastric short-axis view is used to grasp the
eaflet edges. A successful and smooth procedure is
ighly dependent on communication between the
chocardiographer and interventionalist. Guidance
Percutaneous MV Repair Approaches
of edge-to-edge MV repair (Alﬁeri procedure; (top) and percuta-
al annuloplasty (bottom), capitalizing on the relationship
he coronary sinus and the annulus.
Table 3. Noninvasive Assessment for Percutaneous Mitral Valve
Edge-to-edge repair
● Identify mechanism of MR: degenerative ﬂail segment with ﬂail w
● Ensure origin of regurgitant jet is within central two-thirds of coap
● Quantitate MR
● Guide clip deployment
● Assess reduction of MR post-clip and stability of clip placement
Coronary sinus
● Pre-procedural CCT for coronary sinus anatomy
Œ Assess location of coronary sinus relative to mitral annulus: su
Œ Assess location of coronary sinus, left circumﬂex artery and ca
Œ Assess maximal distances between coronary sinus and mitral a
● During and post-procedure
Œ TEE to assess reduction in MR
● Post-procedure
Œ CCT to assess device position and extent of mitral annular remCCT  cardiac computed tomography; MR  mitral regurgitation; TEE  transesopith TEE may be significantly improved with the
se of 3D imaging, allowing for more precise
elivery of the catheter towards the leaflet edges.
oronary sinus (CS) technique. These devices mimic
urgical annuloplasty, which reduces mitral annular
rea by moving the posterior annulus anteriorly or
y decreasing the circumference of the posterior
nnulus. In developing nonsurgical approaches to
V repair, it has been appreciated that the cardiac
eins typically encircle the mitral annulus. These
eins could serve as the anatomic target for percu-
aneously deployed devices that effectively reduce
he ERO by exerting inward pressure on the mitral
nnulus. The typical configuration of the major
ardiac veins is shown in Figure 12. The CS and
reat cardiac vein (GCV) form a continuous cardiac
enous landing zone for a MV repair device deliv-
red transvenously. However, cardiac veins exhibit
reat variability in extent, distribution, and ana-
omic location. The first variable to consider for
uccessful device deployment is the anatomy of the
S-GCV. Distance of the CS-GCV from the
itral annulus in the superior-inferior dimension as
ell as in the radial direction from the center of the
itral valve may be important (27). This variance
ay be an important factor determining the likeli-
ood of procedural success. A device that encircles
rimarily the LA free wall may simulate cor tria-
riatum without affecting a decrease in the MV
RO. Other relevant variables include the length of
he CS-GCV and the extent to which these veins
verlie the mitral annulus. Another important an-
tomic variable is the course of the left circumflex
rtery and its branches (28).
air
1.5 cm vs. ischemic or functional etiology
on line (away from commissures)
r, same level, inferior
veins relative to mitral annulus
lus
lingFigure 11.
Schematic
neous mitr
between tRep
idth
tati
perio
rdiac
nnu
odehageal echocardiography.
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235Coronary venous imaging may be preferred by
he interventionalist for immediate recognition of
natomic landmarks, but does not provide concom-
tant information regarding cardiac and mitral ap-
aratus anatomy that may ultimately determine
rocedural success. Simultaneous transesophageal
r intracardiac echocardiography help overcome
hese deficiencies. The use of cardiac computed
omography allows the simultaneous visualization
f venous, coronary artery, and cardiac anatomy. It
emains to be determined what geometries pose the
reatest risk for myocardial ischemia from extrinsic
oronary compression. Simultaneous rendering of
enous and coronary artery anatomy with cardiac
omputed tomography affords such definition. The
se of CMR has a limited role at the present time,
lthough recent developments in technology may
mprove the utility of this technique (29). A mul-
imodality imaging approach holds promise for
natomic definition of the coronary sinus and LV
uring the procedure. Left ventricular volumes
btained by 3D echocardiography can be superim-
osed on reconstructed images of the coronary sinus
sing high speed rotational coronary venous angiog-
aphy (29). This strategy of integrating echocardio-
raphic and angiographic data to reconstruct coronary
inus and LV anatomy holds great potential.
ntegrated Decision-Making
ow should the clinician use the information gath-
red from the history, examination, and noninvasive
maging to construct the most appropriate manage-
Figure 12. Cardiac Computed Tomography of Coronary Sinus
(Left) Typical conﬁguration of major cardiac veins. The volume-rend
ular vein (AIV) draining into the great cardiac vein (GCV), which in t
vein branches. The posterior interventricular vein (PIV) is also noted
mode of rendering isotropic CT data allows for segmentation of the
cates the anterior interventricular vein. (Right) Coronary artery and
and left circumﬂex coronary artery (arrowhead) lie in the atrioventr
nary sinus in this patient. The potential for myocardial ischemia ind
Ao  aortic valve, LV  left ventricle.ent plan for any individual patient with chronic,onischemic MR? After verification of the diagno-
is, one approach begins with designation of symp-
om status (10). The onset of symptoms is a Class I
ndication for surgical referral, preferably with re-
air, provided: 1) the MR is severe by quantitative
easures and the likely cause of the symptoms
eported and 2) and LV systolic function is normal
r only moderately impaired (EF 0.30, ESD
5.5 cm). For patients with more severe degrees of
V dysfunction (EF 0.30, ESD 5.5 cm), sur-
ery is appropriate when chordal preservation (with
ither repair or replacement) is likely (Class IIa).
There is a relatively greater reliance on noninva-
ive imaging for the management of asymptomatic
atients with nonischemic MR, particularly when
onsidering the indications for surgical repair. Un-
er these circumstances, the risk-benefit analysis
ust be extremely favorable and driven in large
easure by the availability of an expert surgeon
ith a proven track record of outstanding results.
alve replacement is an unacceptable outcome for
he asymptomatic patient. The following questions
ust be answered from the noninvasive data:
. Is the MR severe?
a. No. Establish schedule for clinical and TTE
surveillance.
b. Yes. Establish schedule for clinical and TTE
surveillance and consider whether early sur-
gery might be warranted depending on the
answers to the questions which follow.
. Is LV function preserved?
a. No. If MR is severe and EF 0.60 or ESD
computed tomography (CT) data show the anterior interventric-
becomes the coronary sinus (CS) upon receiving additional lateral
iddle) Coronary sinus in a curved multiplanar CT format. This
ronary sinus along its entire length (arrows). The arrowhead indi-
nary sinus anatomic relationship. Both the coronary sinus (arrow)
ar groove, with the circumﬂex artery lying underneath the coro-
d by extrinsic compression from an overlying venous device exists.ered
urn
. (M
co
coro
icul
uce4.0 cm, refer to surgery (Class I).
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236b. Yes. If MR is severe, and EF 0.60 with
ESD 4.0 cm, consider early surgical referral
depending on likelihood of repair and avail-
ability of surgical expertise (Class IIa).
. Is PA hypertension present?
a. No. If PA systolic pressure 50 mm Hg at rest
and/or 60 mm Hg with exercise, establish
schedule for clinical and TTE surveillance.
b. Yes. If MR is severe and PA systolic pressure
50 mm Hg at rest or 60 mm Hg with
exercise, consider early surgical referral (Class IIa).
. What is the mechanism of the MR and there-
fore the feasibility of primary repair?
a. Myxomatous degeneration/fibroelastic deficiency
b. Other: Barlow’s, congenital, and so on
. Is there a very high (>95%) likelihood of
successful repair?
a. Yes. Consider early referral to an experienced
surgeon at a high volume center of excellenceal. Application of color Doppler flow
sus chronic mitral r
Coll Cardiol 1984;b. No. Establish clinical and TTE surveillance.
Decision-making of this nature requires the col-
aborative input of the clinician, echocardiographer/
mager, and the surgeon. With appropriate training,
ttention to detail, informed understanding of nat-
ral history, more widespread adoption of standard-
zed evaluation and treatment protocols, and further
dvances in surgical and intraoperative manage-
ent, outcomes for patients with nonischemic MR
ill continue to improve. The potential role of
ercutaneous repair has not yet been established.
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